SHRed Consequences of Concussion
Summary
The purpose of this study is to determine whether or not youth and young adults with a history of sport-related concussion or injury in the past 5-15 years differ in symptoms, concentration, brain function, physical performance, body composition, exercise capacity, activity levels, neck function, balance, eye motion, mood, and utilization of health care resources compared to youth and young adults with no history of injury.
Eligibility
Eligible ages: 16 to 33
Accepts healthy participants: Yes
Inclusion criteria:
You may be eligible to participate if:
1. You participated in a previous Sport Injury Prevention Research Centre study when aged 11-18
OR
You participated in youth sport
2. You are 16-33 years old
3. You sustained at least one youth sport-related concussion 5-15 years ago that was assessed by a healthcare professional and/or resulted in time loss from sport of >1 week
OR
You sustained at least one youth sport-related musculoskeletal (bone, muscle, tendon, ligament, soft tissue) injury 5-15 years ago that was assessed by an athletic therapist, physiotherapist or physician and resulted in time loss from sport of >1 week
OR
You have no history of concussion or musculoskeletal injury
Exclusion criteria:
You are not eligible to participate if you:
1. Have a systemic disease (i.e. cancer, arthritis, heart disease)
2. Have a medically diagnosed neurological disorder (i.e. epilepsy, cerebral palsy, multiple sclerosis, vestibular neuritis, balance disorders)
3. Have a medically diagnosed significant psychiatric disorder that is not under control or in remission (i.e. schizophrenia, bipolar disorder)
4. Have a history of concussion or musculoskeletal injury with associated time loss from sport, school, work, and/or activities of daily living of >1 week within the past 12 months
5. Are pregnant at the time of assessment
Participate
Additional information
Contact information
If you are interested in participating, please contact the study research coordinator.
Principal investigator:
Carolyn Emery
Clinical trial:
No
REB-ID:
REB21-0548